Related Experiment Videos
The cost of schizophrenia
1Continuing Care Division, Clarke Institute of Psychiatry, Toronto, Ontario.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|November 1, 1994
Summary
The management of mental illness, particularly schizophrenia, incurs significant costs. Improving care through relapse prevention, community support, and new medications can reduce expenses and enhance patient well-being.
Area of Science:
- Health Economics
- Psychiatry
- Public Health
Background:
- In 1988, mental illness management in the US cost an estimated $129.3 billion.
- Schizophrenia represents the largest expenditure due to high prevalence, early onset, and chronicity.
- Costs include direct (healthcare, drugs), indirect (lost productivity), and caregiver productivity.
Purpose of the Study:
- To review key aspects of schizophrenia care impacting costs.
- To identify strategies for reducing healthcare expenditures for mental illness.
- To explore methods for improving patient quality of life and social functioning.
Main Methods:
- Review of cost-influencing factors in schizophrenia care.
- Analysis of prevention of relapse strategies.
- Evaluation of community care models and new antipsychotic medications.
Main Results:
- Schizophrenia care costs are substantial.
- Relapse prevention, community care, and novel treatments are critical cost determinants.
- Improved patient compliance and integrated care can mitigate expenses.
Conclusions:
- Optimizing schizophrenia care can lead to significant cost savings.
- Community-based care with clinical case management is essential.
- Enhanced treatments and patient compliance improve outcomes and reduce overall economic burden.